Januvia and Buscopan drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Januvia (sitagliptin phosphate) and Buscopan (hyoscine butylbromide). Common drug interactions include pharyngitis among females and interstitial lung disease among males.
The phase IV clinical study analyzes what interactions people have when they take Januvia and Buscopan. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.
What is Januvia?
Januvia has active ingredients of sitagliptin phosphate. It is often used in diabetes. eHealthMe is studying from 72,818 Januvia users. Check the latest studies of Januvia.
What is Buscopan?
Buscopan has active ingredients of hyoscine butylbromide. eHealthMe is studying from 4,828 Buscopan users. Check the latest studies of Buscopan.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
23 people who take Januvia and Buscopan together, and have interactions are studied.

What are the common drug interactions of Januvia and Buscopan, by gender? *:
female:
- Pharyngitis (inflammation of the pharynx, causing a sore throat)
- Urticaria (rash of round, red welts on the skin that itch intensely)
- Arthralgia (joint pain)
- Back pain
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Cholecystitis chronic (long lasting infection of gallbladder)
- Cholecystitis infective (infection of gallbladder capable to infect other organs)
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Constipation
- Dizziness
male:
- Interstitial lung disease
- Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
- Platelet count decreased
- Pyrexia (fever)
- Abdominal pain upper
- Back pain
- Carnitine deficiency
- Cirrhosis alcoholic (chronic disease of the liver marked by degeneration of cells, inflammation, and fibrous thickening of tissue caused by alcoholism)
- Cough
- Dehydration (dryness resulting from the removal of water)
What are the common drug interactions of Januvia and Buscopan, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Hepatitis acute
- Pancreatitis acute (sudden inflammation of pancreas)
40-49:
n/a
50-59:
- Pharyngitis (inflammation of the pharynx, causing a sore throat)
- Arthralgia (joint pain)
- Back pain
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Cholecystitis chronic (long lasting infection of gallbladder)
- Cholecystitis infective (infection of gallbladder capable to infect other organs)
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Constipation
- Dizziness
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
60+:
- Interstitial lung disease
- Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
- Carnitine deficiency
- Cirrhosis alcoholic (chronic disease of the liver marked by degeneration of cells, inflammation, and fibrous thickening of tissue caused by alcoholism)
- Cough
- Dehydration (dryness resulting from the removal of water)
- Diarrhoea
- Dysuria (painful or difficult urination)
- Eczema asteatotic (severe dry skin- during the winter months and in the elderly)
- Hyperkalaemia (damage to or disease of the kidney)
What are the existing conditions these people have? *
- Constipation: 6 people, 26.09%
- High Blood Pressure: 4 people, 17.39%
- Type 2 Diabetes: 4 people, 17.39%
- Pharyngitis (inflammation of the pharynx, causing a sore throat): 4 people, 17.39%
- Gallstones (stone formation by bile component): 4 people, 17.39%
- Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 4 people, 17.39%
- Urticaria (rash of round, red welts on the skin that itch intensely): 3 people, 13.04%
- Back Pain: 3 people, 13.04%
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 3 people, 13.04%
- Cholecystitis (infection of gallbladder): 3 people, 13.04%
* Approximation only. Some reports may have incomplete information.
Do you take Januvia and Buscopan?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Januvia and Buscopan:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Januvia:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Buscopan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Januvia and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Buscopan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Liao KF, Lin CL, Lai SW, Chen WC, "Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: a population-based case-control study in Taiwan", European journal of internal medicine, 2016 Jan .
- Belice T, Yuce S, Kizilkaya B, Kurt A, Cure E, "Noncardiac pulmonary edema induced by sitagliptin treatment", Journal of family medicine and primary care, 2014 Jan .
- Misgar, R. A., Bhat, J. A., Wani, A. I., & Bashir, M. I., "Sitagliptin induced splenic infarcts", Clinical Diabetology, 2014 Jan .
- Stricklin SM, Stoecker WV, Rader RK, Hood AF, Litt JZ, Schuman TP, "Persistent edematous-plaque photosensitivity observed with sitagliptin phosphate (Januvia?)", Dermatology online journal, 2012 Feb .
- Liao KF, Lin CL, Lai SW, Chen WC, "Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: a population-based case-control study in Taiwan", European journal of internal medicine, 2016 Jan .
- Belice T, Yuce S, Kizilkaya B, Kurt A, Cure E, "Noncardiac pulmonary edema induced by sitagliptin treatment", Journal of family medicine and primary care, 2014 Jan .
- Misgar, R. A., Bhat, J. A., Wani, A. I., & Bashir, M. I., "Sitagliptin induced splenic infarcts", Clinical Diabetology, 2014 Jan .
- Stricklin SM, Stoecker WV, Rader RK, Hood AF, Litt JZ, Schuman TP, "Persistent edematous-plaque photosensitivity observed with sitagliptin phosphate (Januvia?)", Dermatology online journal, 2012 Feb .
How the study uses the data?
The study uses data from the FDA. It is based on sitagliptin phosphate and hyoscine butylbromide (the active ingredients of Januvia and Buscopan, respectively), and Januvia and Buscopan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Protamine Sulfate and Simvastatin - 2 seconds ago
- Could Se cause Retroperitoneal Lymphadenopathy? - 3 seconds ago
- Could Ursodeoxycholic Acid cause Myositis? - 7 seconds ago
- Could Claritin cause Muscle Cramps? - 7 seconds ago
- Could Darvocet-N 100 cause Cholecystitis Chronic? - 13 seconds ago
- Could Darvocet-N 100 cause Drug Exposure During Pregnancy? - 14 seconds ago
- Could Darvocet-N 100 cause Acute Coronary Syndrome? - 19 seconds ago
- Could Yaz cause Breast Swelling? - 21 seconds ago
- Drug interactions of Polaramine and Trazodone Hydrochloride - 25 seconds ago
- Could Sandostatin cause Hepatic Lesion? - 34 seconds ago